Kunming Dihon Pharmaceutical Co, a Sino-American joint venture founded in 1997, is one of the leading pharmaceutical companies in Yunnan. It works on innovative, effective chemical medicines and traditional Chinese medicines in five areas of medical need: dermatitis, acne, recurrent oral ulcers, hyperosteogeny, and endometriosis.

From being a small drug manufacturer, Dihon has developed into a large-scale private pharmaceutical company with more than 3,000 employees engaged in R&D, production, marketing and management.

Dihon’s main products include compound ketoconazole cream, compound ketoconazole lotion for scalp disorders, concentrated elixir for women, urea and vitamin E cream, clindamycin hydrochloride and metronidazole liniment, and terbinafine hydrochloride cream. The company owns seven national GMP certified dosage forms and ten products that possess independent intellectual property rights.

By Shi Zihan and edited by Brian Salter